ENANTIOS
molecule characterization method, which addresses critical bottlenecks in traditional drug development
ENANTIOS has raised €1.9M across 1 funding round from 3 investors, most recently a round in Jun 2024. Based in Zurich, Switzerland; active in Deeptech. Data as of 28 Oct 2026.
Zurich, Switzerlandenantios.com ↗
Total raised
€1.9M
€1,874,219
Funding rounds
1
Investors
3
distinct backers
Active since
2024-06
latest 2024-06
Funding by year
EUR raised per yearENANTIOS — funding by year — interactive chart.
Data table
| ENANTIOS — funding by year | |
|---|---|
| 2024 | €1.9M |
Signals
High confidenceRaise-next likelihood15
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-06-27 | Other | €1.9M | Private Investors,Privilège Ventures,Zürcher Kantonalbank | View deal → |
Investors
3Related news
Similar companies
same sector or country- Imec€2.5BBelgium · Deeptech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Climeworks€919MSwitzerland · Cleantech
- Energy Vault€898MSwitzerland · Energy
- ABB E-mobility€705MSwitzerland · Energy
- IQM€578MFinland · Deeptech
Global coverage: FundingData